This funding opportunity invites clinical centers to participate in a consortium testing anti-obesity medication treatment strategies for youth with obesity. Research focuses on optimal timing, dosage, medication class, and adjunct lifestyle therapies to promote healthy development and minimize risks. Centers will collaborate on protocols, data collection, and analyses under a cooperative agreement mechanism.
Eligible applicants include a wide range of U.S.-based organizations such as tribal governments, nonprofits, educational institutions, government entities, and small businesses. Foreign organizations and non-U.S. components are not eligible.